Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 118 record(s)

Req # A-2016-001921

All records as it pertains to Natural Product Number (NPN) 80043184 (Dove Cleartone)

Organization: Health Canada

99 page(s)
July 2022

Req # A-2017-001094

All documents from October 1, 2017 to November 16, 2017 that mention a tax on sugar or fat, a fat tax, a sugar tax, a sugar-sweetened beverage tax (SSB tax), soft drink tax, soda tax, or junk food tax

Organization: Health Canada

46 page(s)
July 2022

Req # A-2017-001792

The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.

Organization: Health Canada

32 page(s)
July 2022

Req # A-2018-000383

All reviewers' reports regarding the cleared Supplement to a New Drug Submission (SNDS) for the pre-filled syringe presentation.

Organization: Health Canada

79 page(s)
July 2022

Req # A-2018-000944

All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.

Organization: Health Canada

44 page(s)
July 2022

Req # A-2018-000999

All correspondence sent by Health Canada to Teva Pharmaceuticals USA between January 1, 1996 to January 1, 1998, with respect to the new drug submission for glatiramer acetate (tradename: COPAXONE, NDS 044430, rec. 1996-07-12), Notice of Compliance date 1997-09-04.

Organization: Health Canada

30 page(s)
July 2022

Req # A-2019-000581

Any correspondence between Johnson and Johnson and Health Canada related to vapour products, vaping products, electronic cigarettes and electronic nicotine delivery systems, from January 1, 2017 to July 18, 2019.

Organization: Health Canada

54 page(s)
July 2022

Req # A-2020-000269

The most current Canadian Risk Management Plan (RMP) and any additional pharmacovigilance activities/risk minimization actions in Canada for TREANDA.

Organization: Health Canada

73 page(s)
July 2022

Req # A-2020-000958

Information regarding Waterite Inc. (NEQ: 1171855852) (hereinafter the "Company"). Any document concerning the Company and the building located at: Address of the building: 1850 Beaulac Saint-Laurent, QC H4R 2E7 Lot: 1 164 332 Land Register of Quebec, Registration Division of Montreal Owner: Les Immeubles Thimens Corp.

Organization: Health Canada

6 page(s)
July 2022

Req # A-2020-000974

All records submitted by the manufacturers to Health Canada for the following test kits: COVID-19 Quantitative Polymerase Chain Reaction (QPCR) Multi Kit, Abbott Realtime SARS-COV-2 Assay, Aries SARS-CoV-2 Assay, PerkinElmer New Coronavirus Nucleic Acid Detection Kit.

Organization: Health Canada

475 page(s)
July 2022
Date modified: